“Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients With COVID -19”. Journal of Pharmaceutical Negative Results 13, no. 2 (June 30, 2022): 82–86. Accessed June 10, 2026. https://pnrjournal.com/index.php/home/article/view/199.